| Literature DB >> 32993736 |
Marcelo José Dos Santos1,2, Maristela Santini Martins3, Fabiana Lopes Pereira Santana3, Maria Carolina Silvano Pacheco Corrêa Furtado3, Fabiana Cristina Bazana Remédio Miname3, Rafael Rodrigo da Silva Pimentel3, Ágata Nunes Brito3, Patrick Schneider3, Edson Silva Dos Santos3, Luciane Hupalo da Silva3.
Abstract
After the World Health Organization declared COVID-19 to be a pandemic, the elaboration of comprehensive and preventive public policies became important in order to stop the spread of the disease. However, insufficient or ineffective measures may have placed health professionals and services in the position of having to allocate mechanical ventilators. This study aimed to identify instruments, analyze their structures, and present the main criteria used in the screening protocols, in order to help the development of guidelines and policies for the allocation of mechanical ventilators in the COVID-19 pandemic. The instruments have a low level of scientific evidence, and, in general, are structured by various clinical, non-clinical, and tiebreaker criteria that contain ethical aspects. Few instruments included public participation in their construction or validation. We believe that the elaboration of these guidelines cannot be restricted to specialists as this question involves ethical considerations which make the participation of the population necessary. Finally, we propose seventeen elements that can support the construction of screening protocols in the COVID-19 pandemic.Entities:
Keywords: Decision making; Ethics; Health care rationing; Pandemics
Mesh:
Year: 2020 PMID: 32993736 PMCID: PMC7522926 DOI: 10.1186/s13054-020-03298-3
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Presentation of instruments for decision-making
| Authors | Country/year | Community participation | Clinical Instrument | Patient | Reassessment | Stratification Criteria | Tiebreakers | Ventilation withdrawal | U |
|---|---|---|---|---|---|---|---|---|---|
| Ardagh [ | NZ/2006 | No | Uninformed | Adult/pediatric | Uninformed | Subjective | Yes | No | 6/8 |
| Christian et al. [ | CA, US/2006 | No | SOFAa, NYHA Classification; Child-Pugh | Adult | 48 hb e 120 h | Objectives | No | Yes | 8/9 |
| Hick & O’Laughlin [ | US/2006 | No | SOFA | Adult/pediatric | Uninformed | Objectives | No | Yes | 9/9 |
| Devereaux et al. [ | US/2008 | No | SOFAa | Adult/pediatric | Daily | Objectives | Yes | Yes | 9/9 |
| Powell, Christ, Birkhead [ | US/2008 | Yes | SOFA, MELD, NYHA Classification | Adult | 48 h e 120 h | Objectives | No | Yes | 8/9 |
| Lin & Anderson-Shaw [ | US/2009 | No | SOFAa; MELD; NYHA Classification | Adult | 48 h e 120 h | Objectives | No | Yes | 8/9 |
| Frolic, Kata, Kraus [ | CA/2009 | No | SOFA; ISS; NYHA Classification; Child-Pugh | Adult | 48 h e 120 h | Objectives | Yes | Yes | 9/9 |
| White et al. [ | US/2009 | No | SOFA | Adult | Uninformed | Objectives | Yes | Yes | 8/9 |
| Christian et al. [ | CA, CN, US, UK,IL/2010 | No | SOFAa, NYHA Classification; Child-Pugh; TRISS | Adult | 48 h e 120 h | Objectives | No | Yes | 8/9 |
| Christian et al. [ | CA, IL, US, CN/2014 | No | SOFA, MELD; NYHA Classification | Adult/pediatric | 72 h and 96 h or as needed | Objectives | Yes | Yes | 9/9 |
| Gall et al. [ | US/2016 | No | POD; DV | Pediatric | Uninformed | Objectives | No | No | 6/9 |
| Daugherty Biddison et al. [ | US/2019 | Yes | SOFA; PELOD-2; NYHA Classification; Child-Pugh | Adult/pediatric | 24 h, 48 h e 120 h | Objectives | Yes | Yes | 9/9 |
| Rubio et al. [ | ES/2020 | No | SOFA, Charlson Comorbidity Index (CCI), NECPAL | Adult/pediatric | Daily | Objectives | No | Yes | 8/9 |
| White & Lo [ | US/2020 | No | SOFA; LAPS2; MELD; NYHA Classification; ECI; COPS2 | Adult/pediatric (from 12 years) | Daily | Objectives | Yes | Yes | 9/9 |
| Swiss Academy Of Medical Sciences [ | CH/2020 | No | NYHA Classification; Child-Pugh; KDIGO | Adult | 48 h | Objectives | No | Yes | 5/9 |
Note: Country: NZ New Zealand, CH Switzerland, ES Spain, CN China, UK United Kingdom, IL Israel, CA Canada, US United State of America
Clinical instrument: SOFA Sequential Organ Failure Assessment, PELOD2 Pediatric Logistic Organ Dysfunction 2, LAPS2 Laboratory-Based Acute Physiology Score, MELD Model for End-Stage Liver Disease, NECPAL Palliative Needs, NYHA Classification New York Heart Association Classification, ISS Injury Severity Score, TRISS Trauma and Injury Severity Score, KDIGO Kidney Disease Improving Global Outcomes, ECI Elixhauser Comorbidity Index, COPS2 Comorbidity Point Score, POD Probability of Death, DV Days on Mechanical Ventilation (DV)
SOFAa = Adapted SOFA; hb = hours; U = Usability
Examples of the application of criteria found in the screening instruments in the allocation of mechanical ventilators
| Section | Ethical values | Criteria found in the instruments | History | Commented examples |
|---|---|---|---|---|
| “Save more lives” | Instruments with exclusion [ | The resource would be allocated to patient B as a result of patient A’s poor prognosis and the high probability of death. Severe trauma is an exclusion criterion in most instruments. | ||
| “Save more lives” | Instruments without exclusion (multiple principles) [ | The resource would be given to Patient A, to the detriment of Patients B and C, who had lower prioritization due to the short and long term prognosis and life cycle. Despite health conditions and severe comorbidities, all patients are included in the screening protocol. | ||
| “Equity” | Life cycle [ | Patient B would have a higher priority to receive the resource, based on the logic that everyone should have the same opportunity to live all the cycles of life. | ||
| “Equality” | Ballot [ | Patients had the same priority score, both in terms of prognosis and life cycle (0–49 years). The resource would be allocated based on chance, in a fair and transparent way. |
Note: SOFA Sequential Organ Failure Assessment, COPD chronic obstructive pulmonary disease
Items to be considered in the construction of the screening protocol
| • Make an extensive review of the literature. | |
| • Examine the existing ethical structures. | |
| • Provide a basis for the chosen ethical structures. | |
| • Define inclusion criteria. | |
| • Establish complementary or non-clinical criteria. | |
| • Combine point systems and mortality predictors, which should be validated, clear, and objective, in intensive therapy. | |
| • Define a prioritization score | |
| • Establish reevaluation periods. | |
| • Use a multiple principle prioritization structure. | |
| • Enable the participation of stakeholders (specialists, clinicians, decision makers, and society) in the definition of the ethical structure and clinical, non-clinical, and tiebreaker criteria. | |
| • Establish tiebreak criteria. | |
| • Define alternative treatments/options for those who will not benefit from the resource. | |
| • Develop specific guidelines for children. | |
| • Pay attention to the usability of the screening instrument. | |
| • Develop an algorithm for the screening instrument. | |
| • Make the established screening policy and criteria public. | |
| • Periodically update the protocol. |